Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Log in to CasePortal
Search Articles
Free Litigation Reports Find Judicial Opinions

Wednesday, April 23, 2025

View Back issues
Wednesday, April 23, 2025

Drug Antitrust

/ July 23, 2013

PHILADELPHIA – Medicis Pharmaceutical paid Impax $55 million to keep a generic form of the acne drug Solodyn (minocycline hydrochloride) off the market, the UFCW Health and Welfare Fund claims in a federal antitrust class action.

Categories / Uncategorized

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

Loading...